Reaching therapeutic doses of CAR-T cell therapies is the longest phase of manufacturing. In this webinar, we cover scalable expansion processes that can help support increasing demand.
What you Will Learn
- Expanding CAR-T cells in automated stirred-tank bioreactors
- Scaling culture from 15 mL to 1 L
- Identifying optimal perfusion parameters for CAR-T cell growth and function